We regret that the acknowledgement section accompanying the above article was published in an incomplete form. The full acknowledgement section of this article is as follows.
Highfield Communication Consultancy, Oxford, UK, funded by Bayer HealthCare, provided editorial support in the development of this paper. All analyses were carried out by the study sponsor and the Data Review Committee was responsible for validating all clinical failure data. The authors thank Geneviève Faragó (Bayer Inc., Toronto, ON, Canada), study manager, for excellent and dedicated support throughout the trial and Richard Kay (RK Statistics Ltd, Bakewell, UK) for independent statistical assessment. The authors thank the coordinating principal investigators for their extensive contribution in the study: Dr Jordi Roig, Andorra; Professor Yves Sibille, Belgium; Professor Tom Schaberg, Germany; Dr Eamonn Shanahan, Ireland; Professor Fernando De Benedetto, Italy; Dr Nadeem Rizvi, Pakistan; Dr João Cardoso, Portugal; Dr Eduard Monsó, Spain; and Dr John Langan, UK. They are also grateful to all physicians who enrolled patients in the study; a full list is given in the online supplementary material.
- ©ERS 2012
